Charlie Johnson, CEO of biotechnology company ADC Bio, explains how substantial cost savings and faster time to market is achievable through the novel concept of combining the bioconjugation and purification steps.
As an advanced manufacturing concept, integrated bioconjugation is highly promising – and is now under development – with the potential to achieve huge efficiencies in the ADC production pipeline.